Sigma Planning Corp Has $1.97 Million Stake in Cardinal Health, Inc. $CAH

Sigma Planning Corp trimmed its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.4% during the second quarter, HoldingsChannel reports. The fund owned 11,738 shares of the company’s stock after selling 937 shares during the period. Sigma Planning Corp’s holdings in Cardinal Health were worth $1,972,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in CAH. iA Global Asset Management Inc. increased its stake in Cardinal Health by 72.8% in the 2nd quarter. iA Global Asset Management Inc. now owns 23,933 shares of the company’s stock valued at $4,021,000 after buying an additional 10,083 shares during the last quarter. GHP Investment Advisors Inc. increased its stake in Cardinal Health by 2.4% in the 2nd quarter. GHP Investment Advisors Inc. now owns 39,771 shares of the company’s stock valued at $6,682,000 after buying an additional 941 shares during the last quarter. Plato Investment Management Ltd increased its stake in Cardinal Health by 61.0% in the 2nd quarter. Plato Investment Management Ltd now owns 8,437 shares of the company’s stock valued at $1,412,000 after buying an additional 3,197 shares during the last quarter. Kesler Norman & Wride LLC acquired a new stake in Cardinal Health in the 2nd quarter valued at $763,000. Finally, Haven Private LLC increased its stake in Cardinal Health by 2.9% in the 2nd quarter. Haven Private LLC now owns 5,358 shares of the company’s stock valued at $900,000 after buying an additional 149 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of CAH stock opened at $195.30 on Wednesday. The company has a market capitalization of $46.40 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.39 and a beta of 0.71. The company has a 50-day simple moving average of $157.00 and a 200 day simple moving average of $155.47. Cardinal Health, Inc. has a 52 week low of $110.63 and a 52 week high of $197.67.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is presently 30.77%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CAH shares. TD Cowen lifted their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research note on Monday. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Jefferies Financial Group set a $220.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Monday. Wells Fargo & Company restated an “overweight” rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Evercore ISI boosted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Eleven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $200.54.

Insider Buying and Selling at Cardinal Health

In related news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last ninety days. Insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.